- Home
- Free App Analytics
- SARCULATOR
- SARCULATOR Vs. ASCO Guidelines
SARCULATOR vs ASCO Guidelines Usage & Stats
This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician.
Two kinds of predictions are possible:
- RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. .
- STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.
- Apple App Store
- Free
- Medical
Store Rank
- -
The ASCO Guidelines app is your go-to tool for implementing guideline recommendations into practice. This user-friendly app provides health care providers, patients, and caregivers with the recommended cancer care options for a variety of cancer types. It also includes interactive tools to inform treatment decisions at the point of care, thus increasing the quality of care provided to patients. The ASCO app is free to members and nonmembers, kept up to date, and will continue to grow as more guidelines and tools are added.
- Apple App Store
- Free
- Medical
Store Rank
- -
SARCULATOR vs. ASCO Guidelines ranking comparison
Compare SARCULATOR ranking trend in the past 28 days vs. ASCO Guidelines
Rank
No Data Available
SARCULATOR vs. ASCO Guidelines ranking by country comparison
Compare SARCULATOR ranking trend in the past 28 days vs. ASCO Guidelines
All categories
No Data Available
Medical
Compare to any site with our free trial
SARCULATOR VS.
ASCO Guidelines
January 8, 2025